Page last updated: 2024-11-06

prednisolone and Cancer of ILEUM

prednisolone has been researched along with Cancer of ILEUM in 6 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"The risk of colorectal cancer was not increased, either in the total group of patients or in patients with colonic Crohn's disease exclusively (standardized morbidity ratio, 1."1.32Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. ( Binder, V; Jess, T; Langholz, E; Munkholm, P; Winther, KV, 2004)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fossati, M1
Buzzonetti, A1
Monego, G1
Catzola, V1
Scambia, G1
Fattorossi, A1
Battaglia, A1
Tokura, T1
Nishikawa, S1
Yachi, T1
Umehara, M1
Umehara, Y1
Murata, A1
Takahashi, K1
Morita, T1
Campbell, W1
Baird, E1
Murtagh, K1
Eedy, D1
Hannon, R1
Pranesh, N1
Motegi, S1
Nishizaki, Y1
Muramatsu, C1
Nakamura, H1
Kobayashi, F1
Shiozawa, H1
Kamochi, J1
Itakura, M1
Shibuya, M1
Ogawa, T1
Matsuzaki, S1
Jess, T1
Winther, KV1
Munkholm, P1
Langholz, E1
Binder, V1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Two-arm, Randomized, Open-label, Phase IIIb Study Investigating the Safety of a 3 Hour i.p. Infusion of Catumaxomab With and Without Prednisolone Premedication in Patients With Malignant Ascites Due to Epithelial Cancer[NCT00822809]Phase 3230 participants (Actual)Interventional2008-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for prednisolone and Cancer of ILEUM

ArticleYear
Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3).
    Gynecologic oncology, 2015, Volume: 138, Issue:2

    Topics: Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cell Line, Tumor; F

2015

Other Studies

5 other studies available for prednisolone and Cancer of ILEUM

ArticleYear
[A Case of Extranodal Nasal Type, NK/T Cell Lymphoma in the Ileum with Perforated Peritonitis during Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome;

2015
Post-operative pyoderma gangrenosum in association with ileal carcinoid tumour.
    The Ulster medical journal, 2010, Volume: 79, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Carcinoid Tumor; Colectomy; Humans; Ileal Neoplasms; Laparoscopy; Ma

2010
Lymphoma in an ileostomy.
    Postgraduate medical journal, 2002, Volume: 78, Issue:920

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Combined Modal

2002
Hemophagocytic syndrome in ileum-origin B-cell lymphoma.
    Journal of gastroenterology, 2003, Volume: 38, Issue:10

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols;

2003
Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.
    Alimentary pharmacology & therapeutics, 2004, Feb-01, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hor

2004